Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Ajanta Pharma Limited debt and liabilities for a breakdown of total debt and financial obligations.

Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jointown Pharmaceutical Group Co Ltd
SHG:600998
0.015x
China Galaxy Securities Co Ltd
F:CGL
-0.495x
Grandblue Environment Co Ltd
SHG:600323
0.085x
Carnival Corporation & plc
F:POH1
0.116x
Peyto Exploration&Development Corp
TO:PEY
0.081x
Kenon Holdings
TA:KEN
0.034x
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX
21.854x
KENON HLDGS LTD
F:76N
0.032x

Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Ajanta Pharma Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs37.90 Billion
≈ $409.91 Million
Rs11.57 Billion
≈ $125.15 Million
0.305x +38.73%
2024-03-31 Rs35.67 Billion
≈ $385.80 Million
Rs7.85 Billion
≈ $84.90 Million
0.220x -5.83%
2023-03-31 Rs33.88 Billion
≈ $366.40 Million
Rs7.92 Billion
≈ $85.63 Million
0.234x +35.73%
2022-03-31 Rs32.64 Billion
≈ $353.03 Million
Rs5.62 Billion
≈ $60.78 Million
0.172x -10.50%
2021-03-31 Rs29.96 Billion
≈ $323.97 Million
Rs5.76 Billion
≈ $62.33 Million
0.192x +9.46%
2020-03-31 Rs25.99 Billion
≈ $281.06 Million
Rs4.57 Billion
≈ $49.40 Million
0.176x +5.29%
2019-03-31 Rs22.45 Billion
≈ $242.81 Million
Rs3.75 Billion
≈ $40.53 Million
0.167x +19.39%
2018-03-31 Rs20.41 Billion
≈ $220.77 Million
Rs2.85 Billion
≈ $30.87 Million
0.140x -63.95%
2017-03-31 Rs15.68 Billion
≈ $169.54 Million
Rs6.08 Billion
≈ $65.76 Million
0.388x +39.29%
2016-03-31 Rs11.72 Billion
≈ $126.75 Million
Rs3.26 Billion
≈ $35.30 Million
0.278x -16.18%
2015-03-31 Rs8.41 Billion
≈ $90.96 Million
Rs2.79 Billion
≈ $30.22 Million
0.332x -7.21%
2014-03-31 Rs5.93 Billion
≈ $64.16 Million
Rs2.12 Billion
≈ $22.97 Million
0.358x -40.32%
2013-03-31 Rs3.93 Billion
≈ $42.51 Million
Rs2.36 Billion
≈ $25.50 Million
0.600x +133.59%
2012-03-31 Rs2.98 Billion
≈ $32.23 Million
Rs765.41 Million
≈ $8.28 Million
0.257x -41.57%
2011-03-31 Rs2.29 Billion
≈ $24.75 Million
Rs1.01 Billion
≈ $10.88 Million
0.440x -14.54%
2010-03-31 Rs1.85 Billion
≈ $20.00 Million
Rs951.16 Million
≈ $10.29 Million
0.514x +133.60%
2009-03-31 Rs1.57 Billion
≈ $16.99 Million
Rs345.92 Million
≈ $3.74 Million
0.220x +55.96%
2008-03-31 Rs1.35 Billion
≈ $14.62 Million
Rs190.81 Million
≈ $2.06 Million
0.141x -22.80%
2007-03-31 Rs1.16 Billion
≈ $12.50 Million
Rs211.30 Million
≈ $2.29 Million
0.183x -21.67%
2006-03-31 Rs1.09 Billion
≈ $11.74 Million
Rs253.45 Million
≈ $2.74 Million
0.233x +446.42%
2005-03-31 Rs978.24 Million
≈ $10.58 Million
Rs-65.93 Million
≈ $-713.01K
-0.067x --

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$3.81 Billion
Rs352.66 Billion INR
Market Cap Rank
#4268 Global
#180 in India
Share Price
Rs2822.70
Change (1 day)
+0.66%
52-Week Range
Rs2388.40 - Rs3119.50
All Time High
Rs3395.67
About

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more